Anti-B7-H3 (Research Grade Enoblituzumab Biosimilar) sinobiological 68202-H001

$714.00
In stock
SKU
68202-H001
Catalog No.SizePrice (USD)
68202-H001-55 mg$740.55
68202-H001-2525 mg$2,221.66
68202-H001-500500 µg$222.17

General Information

Product nameAnti-B7-H3 (Research Grade Enoblituzumab Biosimilar)
Species reactivityReacts with: Human
SpecificityB7-H3
PreparationThis product is a recombinant monoclonal antibody expressed from HEK293 cells.
SourceIgG1, Kappa
PurificationProtein A
FormulationHistidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0
ConjugateUnconjugated
Endotoxin≦ 1 EU/mg
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageAntibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

title: A monoclonal antibody targeting B7-H3 in human embryonic stem cells exhibits anti-tumor activity in hepatocellular carcinoma xenografts
authors: San Ha Han; Hyosun Seo; ...; Chun Jeih Ryu
journal: Translational Oncology
date: 2026-02-01
pmid: 41389673
cited_by_count: 0
techniques: ADCC Assay; Biomarker Discovery; Blocking Assay; Concentration Assay; Control; Immunoprecipitation; Injection; Isolation; Lysis; Membrane; Over Expression; Saline; Western Blot
bioz_score: 94

title: Improving Targeted Delivery and Antitumor Efficacy of TRAIL through Fusion with a B7H3-Antagonistic Affibody.
authors: Xiaomeng Lu; Xinyu Zhan; ...; Dianlong Jia
journal: Molecular Pharmaceutics
date: 2024-12-02
pmid: 39620978
doi: 10.1021/acs.molpharmaceut.4c00891
cited_by_count: 0
techniques: Expressing; Flow Cytometry; Fluorescence; Lysis; Microscopy; Staining; Western Blot
bioz_score: 94

title: Development of a Human B7-H3-Specific Antibody with Activity against Colorectal Cancer Cells through a Synthetic Nanobody Library
authors: Jingxian Li; Bingjie Zhou; ...; Ali Zarrabi
journal: Bioengineering
date: 2024-04-15
pmid: 38671802
doi: 10.3390/bioengineering11040381
pmcid: 11047927
cited_by_count: 6
techniques: Bicinchoninic Acid Protein Assay; Expressing; Incubation; Knockdown; Membrane
bioz_score: 94

title: B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo.
authors: Qian Zhang; Zhiqiang Zhang; ...; Ziming Zhang
journal: BMC Cancer
date: 2022-11-03
pmid: 36320072
doi: 10.1186/s12885-022-10229-8
cited_by_count: 25
techniques: Immunohistochemistry; Immunostaining; Labeling; Microscopy; Staining
bioz_score: 93

title: B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vitro
authors: Qian Zhang; Zhiqiang Zhang; ...; Ziming Zhang
journal: Europe PMC
date: 2022-04-26
doi: 10.21203/rs.3.rs-1570552
cited_by_count: 0
techniques: Immunostaining; Labeling; Microscopy; Staining
bioz_score: 94

title: Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
authors: Jenny Mattsson; Ludvig Ekdahl; ...; Björn Nilsson
journal: Nature Communications
date: 2021-02-24
pmid: 33627649
doi: 10.1038/s41467-021-21518-4
pmcid: 7904777
cited_by_count: 3
techniques: Blocking Assay; Flow Cytometry
bioz_score: 94

MDSD

MSDS

Reviews

Write Your Own Review
You're reviewing:Anti-B7-H3 (Research Grade Enoblituzumab Biosimilar) sinobiological 68202-H001
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.